Facebook Pixel image RizeGreymon BT17-037 | Digimon digimon Cards

digimon > Cards > RizeGreymon BT17-037

RizeGreymon BT17-037 image
set min mtgo
- NZ$ 0.00 0.0 tix
Icons of mtg
Name RizeGreymon BT17-037 Edit card
Type Digimon - ultimate vaccine cyborg
Description Effect [Your Turn] While you have a suspended Tamer, this Digimon gets +3000 DP and gains <Piercing>.[When Digivolving] [When Attacking] By suspending 1 of your yellow Tamers, 1 of your opponent's Digimon gets -3000 DP for the turn. Inherited EffecSee more
Artist Digimon Card Game
Set Digimon card game secret crisis [bt17] #BT17-037
Wallpaper RizeGreymon BT17-037 Crop image Wallpaper download
Image RizeGreymon BT17-037 Full hd image download
⚠️

Tierlist

No Rank

Grade it yourself

Meta types

Edit card

Legality between formats

Edit card

Table of contents

About RizeGreymon BT17-037

RizeGreymon BT17-037, Digimon - ultimate vaccine cyborg, designed by Digimon Card Game first released in Jul, 2024 in the set Secret Crisis.

This RizeGreymon BT17-037 card would greatly benefit a yellow Digimon deck that focuses on utilizing Tamers for powerful effects. Its ability to boost its DP and gain Piercing while you have a suspended Tamer, along with the ability to reduce an opponent's Digimon's DP by suspending a Tamer, provides strong offensive capabilities. Additionally, the inherited effect of placing a Marcus Damon from the trash on top of your security stack when a yellow or red Tamer is deleted adds resilience to the deck. While there may be other powerful cards to consider, such as those with additional effects or synergies, RizeGreymon BT17-037 is definitely a strong contender for inclusion in a yellow Digimon deck.

Where to buy

Seller image Ebay.com

Visit store
Seller image Printing proxies

$ 0.75 Visit store

*This site contains affiliate links for which we may be compensated

Group by

Price alert ?

Alert me when price gets to

Price trend history

loading
Profile imageSign in and join the conversation

— Comments0

User profile image

Be the first to comment